Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

Clinical trial NCT00908752 · COMPLETED

Trial details

NCT number: NCT00908752
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2009-07-20
Primary completion: 2012-09-28
Enrollment: 734

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.